Cancer Immunotherapy Market Set for 14.5% Growth to USD 483.04 billion by 2034
From USD 145 billion in 2025 to USD 483.04 billion in 2034, a 14.5% compound annual rate.
Market findings and research announcements from the CDI research team. Showing 1441–1452 of 1656.
From USD 145 billion in 2025 to USD 483.04 billion in 2034, a 14.5% compound annual rate.
From USD 1.16 billion in 2025 to USD 2.33 billion in 2034, a 8.1% compound annual rate.
From USD 11.2 billion in 2025 to USD 19.95 billion in 2034, a 6.73% compound annual rate.
From USD 5.4 billion in 2025 to USD 10.02 billion in 2034, a 7.08% compound annual rate.
From USD 9.55 billion in 2025 to USD 12.49 billion in 2034, a 2.84% compound annual rate.
Market reaches USD 3.13 billion by 2034, up from USD 1.65 billion in 2025, at a 7.39% CAGR.
Market reaches USD 1215.9 billion by 2034, up from USD 612.4 billion in 2025, at a 7.93% CAGR.
From USD 285 billion in 2025 to USD 475.8 billion in 2034, a 5.78% compound annual rate.
From USD 3.15 billion in 2025 to USD 5.1 billion in 2034, a 5.5% compound annual rate.
Market reaches USD 4.84 billion by 2034, up from USD 2.5 billion in 2025, at a 7.52% CAGR.
From USD 4.1 billion in 2025 to USD 8.97 billion in 2034, a 9.04% compound annual rate.
From USD 33 billion in 2025 to USD 130.4 billion in 2034, a 15.92% compound annual rate.
For comment on a published finding, or to request the full study behind a release, contact the research team.